Ccl8.0

Cat's Claw

Cat's Claw (Uncaria tomentosa)

Amazon rainforest vine with immune-modulating and anti-inflammatory properties, traditionally used for arthritis and infections.

immunityimmuneimmuneanti-inflammatoryjoint healthAmazon
Last reviewed: January 1, 2025
8.0/10
40+ studies
Evidence
moderate
Safety
250-350mg standardized extract or 1-3g dried bark, 2-3x daily
Dose
4-12 weeks
Time to Effect
Standardized extract (3% oxindole alkaloids)
Best Form

Cat's Claw is a woody vine from the Amazon rainforest named for its hook-like thorns. Used by indigenous peoples for millennia, it contains oxindole alkaloids and other compounds with immune-modulating, anti-inflammatory, and antioxidant effects. Research supports benefits for osteoarthritis, rheumatoid arthritis, and immune function.

Mechanisms of Action

🛡️
Immune Modulation

Enhances and regulates immune function

🔥
Anti-Inflammatory

Reduces inflammatory mediators

✨
Antioxidant

Protects against oxidative damage

Recommended Dose

250-350mg standardized extract or 1-3g dried bark, 2-3x daily

250mg1000mg

Optimal Timing

  • With meals

Take with food

Best Form

Standardized extract (3% oxindole alkaloids)

Alternatives: Dried bark capsules, Tea, Tincture

Two species exist — Uncaria tomentosa is most researched. Some products use U. guianensis.

Duration

Minimum: 4 weeks

Optimal: 12 weeks

Cycling: 8-12 weeks on, 2-4 weeks off recommended for long-term use.

Note: Taking with food reduces potential GI upset. Split into 2-3 doses for best results.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🦵
Joint Support

Reduced arthritis symptoms

4-8 weeks
55% of users notice thispositive
🛡️
Immune Enhancement

Improved immune function

2-4 weeks
50% of users notice thispositive
🔥
Inflammation Reduction

Lower inflammatory markers

4-8 weeks
50% of users notice thispositive
ModerateMax safe dose: Up to 350mg extract 3x daily used in studies
🔴
Pregnant/nursing

Avoid — traditionally contraindicated

🔴
Autoimmune conditions

Avoid or use under medical supervision

Who Should NOT Take This

  • Autoimmune diseases (may stimulate immune system)
  • Before surgery (stop 2 weeks prior)
  • Organ transplant recipients

Drug Interactions

Blood thinnersmoderate

May increase bleeding risk

Immunosuppressantsmoderate

May counteract immunosuppression

Blood pressure medicationsmild

May have additive blood pressure lowering effects

CYP3A4 substratesmild

May affect drug metabolism

Possible Side Effects

GI upsetuncommon

Tip: Take with food

Dizzinessrare

Tip: Reduce dose

Headacherare

Tip: Usually resolves

Warnings

  • Avoid in autoimmune diseases (may stimulate immune system)
  • Stop 2 weeks before surgery
  • Not for transplant recipients on immunosuppressants

Top studies from 40+ peer-reviewed papers

systematic-review
DOI

Marques O et al. • International journal of molecular sciences (2025)

“The present work emphasizes the current pharmacological properties of Uncaria tomentosa, evidencing its therapeutic benefits and encouraging further research on this medicinal plant.”
Key Findings:
  • The present paper reviews research progress relating to the ethnobotany, phytochemistry and pharmacology of Ut, and some promising research routes are also discussed.
  • We highlight the centrality of its different biological activities, such as antioxidant, anti-inflammatory, antiproliferative, antiviral, and antinociceptive, among others.
  • The present work emphasizes the current pharmacological properties of Uncaria tomentosa, evidencing its therapeutic benefits and encouraging further research on this medicinal plant.
meta-analysisn=137
DOI

Roberts KE et al. • The Cochrane database of systematic reviews (2022)

“AIMSS are chronic and complex symptoms with a significant impact on women with early breast cancer taking AI.”
Key Findings:
  • The two studies, investigating vitamin D and omega-3 fatty acids, showed a treatment effect with 95% CIs that did not include an MCID for pain.
  • Systemic therapies may have little to no effect on grip strength (RR 1.08, 95% CI 0.37 to 3.17; 1 study, 137 women) or on women continuing to take their AI (RR 0.16, 95% 0.01 to 2.99; 1 study, 147 women).
  • The evidence suggests little to no effect on HRQoL and BCS-QoL from baseline to the end of intervention (the same single study; 44 women, both quality of life outcomes showed a treatment effect with 95% CIs that did include an MCID).
  • The evidence is very uncertain for outcomes assessing incidence of AIMSS (RR 0.82, 95% CI 0.63 to 1.06; 2 studies, 240 women) and the safety of systemic therapies (4 studies, 344 women; very low-certainty evidence).
systematic-review
DOI

Carvalho-Silva JM et al. • The Journal of prosthetic dentistry (2025)

“Gels formulated with natural antimicrobials such as Z. multiflora, U. tomentosa, P. granatum, propolis, and clove and cinnamon showed higher or similar antimicrobial efficacy to conventional antifungals in the treatment of DS.”
Key Findings:
  • Gels formulated with natural antimicrobials such as Z. multiflora, U. tomentosa, P. granatum, propolis, and clove and cinnamon showed higher or similar antimicrobial efficacy to conventional antifungals in the treatment of DS.
  • The biocompatibility of experimental gels based on natural agents should be evaluated.
  • Further research warranted to confirm findings
systematic-review
DOI

Plazas E et al. • Molecules (Basel, Switzerland) (2025)

“These findings highlight the immense potential of bioactive compounds from tropical American plants as modulators of immune-inflammatory pathways, providing a foundation for developing effective therapeutic agents to counteract the severe effects of cytokine storms.”
Key Findings:
  • Key polyphenols, like quercetin and luteolin, found in plants such as Achyrocline satureioides and Mangifera indica demonstrate the downregulation of NF-κB and inhibition of pro-inflammatory cytokines.
  • Alkaloids, such as berberine and mitraphylline, isolated from Berberis species and Uncaria tomentosa, respectively, have shown potent effects in suppressing nitric oxide production and regulating inflammasomes.
  • Terpenoids, including parthenolide from Tanacetum parthenium and curcumol from Curcuma longa, exhibit multitarget activity, reducing cytokine levels and inhibiting key inflammatory enzymes like COX-2 and iNOS.
  • These findings highlight the immense potential of bioactive compounds from tropical American plants as modulators of immune-inflammatory pathways, providing a foundation for developing effective therapeutic agents to counteract the severe effects of cytokine storms.
systematic-reviewn=17
DOI

Inácio Silveira DQ et al. • The Journal of prosthetic dentistry (2023)

“Certainty in the body of evidence that natural products might be appropriately used in the treatment of denture stomatitis is low.”
Key Findings:
  • Certainty in the body of evidence that natural products might be appropriately used in the treatment of denture stomatitis is low.
  • Well-designed randomized controlled trials are still needed to evaluate the topic better because there is high heterogeneity among the studies.
  • Further research warranted to confirm findings
38
Total Studies
8.0/10
Avg Quality
11-137
Sample Size Range
2000-2025
Research Span

Study Type Distribution

Systematic Review
24
Observational
6
RCT
5
In Vitro
2
Meta-Analysis
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.